Hepatocellular Carcinoma 对比 IMedicus 的使用情况和统计数据

@Point of Care™ With Cognitive AI is a clinical decision-making mobile platform. Hepatocellular Carcinoma @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care. With Cognitive AI, clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Cognitive AI, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care. Hepatocellular Carcinoma @Point of Care™ is designed to: • Support discovery and practice change • Provide relevant, evidence-based disease-specific medical content • Improve patient outcomes at the point of care Features: • Continually updated Hepatocellular Carcinoma content • Topics in diagnosis, treatment, and care management developed with expert physician authors • Case studies, videos, and interviews • Access to actionable patient-recorded data • Detailed reference list with access to original sources • Continuing medical education credit (CME/CE) • Surveys and peer polling • Patient education resources to share with patients
  • Apple 应用商店
  • 免费
  • 医疗

商店排名

- -

i-medicus leverages the best-in-class Telehealth solutions whether for patients, doctors, or organisations. People can connect anywhere, anytime, from any device. We are the most efficient and effective of all the Telehealth service providing platforms. I make this apparently extravagant claim because, as a physician of many years standing I have used many such platforms. Several have been quite good but I have found every single one of them to be deficient in one or more detail – either something that I wished were included or something included that didn’t quite do the job in the way I wanted. Our i-medicus app enables patients instantly to access an appropriate healthcare practitioner from our comprehensive roll of expert specialists. In addition, doctors have access to all features of patients’ history and will find a huge patient engagement with our app. Disclaimer Thank you for choosing i-medicus app for your healthcare needs. Before using our app, we request you to read and acknowledge the following disclaimer: i-medicus app is a telemedicine service that allows patients to connect with licensed medical professionals for medical consultations and advice through video or audio calls. This app is not intended to replace traditional in-person medical consultations, and it should not be considered a substitute for a face-to-face consultation with a licensed medical professional. The medical advice provided through our app is based on the information provided by the patient. Therefore, it is important to provide accurate and complete information about your medical history, current symptoms, and any medication you are taking. Our app is intended to be used for non-emergency medical situations only. If you are experiencing a medical emergency, please call your local emergency services or go to the nearest hospital immediately. i-medicus app does not guarantee a diagnosis, and the medical advice provided through the app is solely based on the information provided by the patient. Therefore, it is important to consult with a licensed medical professional before making any medical decisions or taking any medication. The medical advice provided through our app is for informational purposes only and does not create a doctor-patient relationship. The use of i-medicus app does not constitute the establishment of a doctor-patient relationship.
  • Apple 应用商店
  • 免费
  • 医疗

商店排名

- -

Hepatocellular Carcinoma与IMedicus排名比较

对比 Hepatocellular Carcinoma 与 IMedicus 在过去 28 天内的排名趋势

排名

没有可用的数据

Hepatocellular Carcinoma 对比 IMedicus 的排名,按国家/地区比较

对比 Hepatocellular Carcinoma 与 IMedicus 在过去 28 天内的排名趋势

无数据可显示

通过免费试用版比较任何网站

开始使用
Hepatocellular Carcinoma VS.
IMedicus

一月 8, 2025